Last updated on December 2006

Israel Multicenter D-Serine Study (IMSER) for the Treatment of Schizophrenia


Brief description of study

The goal of the present study is to evaluate the effect of D-serine, added to antipsychotic treatment, on negative and cognitive symptoms in schizophrenia. The investigators are hypothesizing that D-serine will improve cognitive functioning and negative symptoms.

Clinical Study Identifier: NCT00138775

Find a site near you

Start Over